GLP-1 Maintenance Dose Cost 2026 — What Indefinite Therapy Really Costs

Why maintenance is the right planning horizon

STEP-4 (semaglutide) and SURMOUNT-4 (tirzepatide) both demonstrated that stopping GLP-1 therapy after goal weight is reached produces meaningful regain within 6–12 months. The obesity-medicine field has consequently shifted its framing from “weight-loss treatment” to “chronic-disease management.” You budget for a GLP-1 the way you budget for a statin or an ACE inhibitor — indefinitely, until evidence changes.

Annual cost by path (2026)

• Insurance + savings card ($25–$100 copay): $300–$1,200/year
• LillyDirect Zepbound vial ($499/mo): $5,988/year
• NovoCare Wegovy vial ($499/mo): $5,988/year
• Compounded tirzepatide ($199–$449/mo): $2,388–$5,388/year
• Zepbound pen list ($1,060/mo): $12,720/year
• Wegovy pen list ($1,349/mo): $16,188/year

Add $200–$800/year for quarterly clinic visits and labs. Add $60–$240/year for supplies if on vials.

Ten-year cost scenarios (no discounting)

• Best case (insurance + savings card $25/mo): ~$3,000
• Vial self-pay ($499/mo): ~$59,880
• Compounded stable ($299/mo): ~$35,880
• Full list price pens: ~$127,000–$162,000

The spread is enormous. If you can get commercial coverage, your effective GLP-1 cost over a decade is less than a used car. If you can’t and end up at list price, you’re talking about a house downpayment. The effort invested in securing coverage has an extremely high expected value.

Budget-protection moves

1. Document comorbidities aggressively every visit. Your ICD-10 codes drive coverage.
2. Renew your manufacturer savings card annually — they don’t auto-roll.
3. Max your HSA. Triple tax advantage compounds over a decade.
4. Avoid 90-day fills unless your plan gives a meaningful discount for them; missing a savings-card application to a 90-day fill can erase hundreds in copay savings.
5. If your employer plan excludes AOMs, ask HR benefits to add them at the next renewal — SELECT and SURMOUNT-OSA data strengthen the ROI pitch.
6. If you’re self-paying, reassess every six months — manufacturer programs reprice, and your plan’s formulary can change at January 1.

What to do if cost forces a pause

If finances genuinely force a pause, a structured 4–6 week taper (dropping to the prior dose for two weeks, then half of that for two weeks) is kinder than stopping cold. Maintain your protein intake (1.2–1.6 g/kg goal body weight) and resistance training through the pause to preserve lean mass. Monitor weight weekly during the pause. If regain exceeds 5% of your goal weight, resume therapy before the loop re-establishes.